Niagen Bioscience, Inc. (NAGE) — Capital Reinvestment Ratio
Niagen Bioscience, Inc. (NAGE) has a Capital Reinvestment Ratio of 0.01x as of September 2025, meaning it reinvests 0% of its operating cash flow ($3.69 Million) in capital expenditures ($24.00K). See net asset quality index of Niagen Bioscience, Inc. to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Niagen Bioscience, Inc. Capital Reinvestment Ratio (2023–2024)
This chart tracks Niagen Bioscience, Inc.'s Capital Reinvestment Ratio across 2 annual periods. Check total reinvestment intensity of Niagen Bioscience, Inc. to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Niagen Bioscience, Inc. (2023–2024)
Year-by-year Capital Reinvestment Ratio for Niagen Bioscience, Inc. from 2023 to 2024. For live market cap and broader valuation context, see Niagen Bioscience, Inc. (NAGE) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.01x | $12.11 Million | $163.00K | ▼ -35.3% |
| 2023 | 0.02x | $7.12 Million | $148.00K | — |